SimBioSys, a TechBio company that is redefining precision medicine for cancer by utilizing artificial intelligence (AI) and biophysical modeling to unlock the power of spatial biophysics, announced today that it has partnered with Mayo Clinic on a strategic collaboration agreement to develop innovative digital precision medicine treatments for patients with breast cancer.
SimBioSys and Mayo Clinic Enter Strategic Collaboration to Advance AI-powered Digital Precision Medicine Platform for Cancer Patients streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Atossa Therapeutics (ATOS) Receives Authorization from FDA to Initiate its Phase 2 Study of Neoadjuvant (Z)-endoxifen in Premenopausal Women with ER+/HER2- Breast Cancer streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.